ENIVACHB
Panacea Biotec Q3 net profit at Rs 83 crorePanacea Biotec today posted a net profit of Rs 82.79 crore for the third quarter ended December 31, 2013.
Easyfive TT vaccine to be back in WHO list: Panacea BiotecPanacea Biotec is hopeful of resuming supplies of its pentavalent vaccine 'Easyfive TT', which prevents Tetanus and Hepatitis B.- Panacea Biotec withdraws oral polio vaccine from WHO listDrug firm Panacea Biotec today said it has withdrawn its oral polio vaccine from the World Health Organisation's list of pre-qualified vacc...
- WHO disqualifies 3 vaccines of Panacea BiotecPanacea Biotec scrip fell 20% to Rs 144.90 on Thursday after the biotechnology firm disclosed that WHO has disqualified its 3 combination v...
Load More- WHO disqualifies 3 vaccines of Panacea Biotec